From pathogen to ally: engineering viruses to treat disease

12 December 2011

Thursday 1 December 2011

Professor Mary Collins (UCL Immunology)

Recombinant DNA technology has been in widespread use since the 1980s. It has allowed the engineering of viral genomes to produce a number of safe and useful medicines. To mark World AIDS Day, this lecture discusses the development of engineered viruses, such as HIV, to treat rare genetic disorders – “gene therapy”- and the use of these engineered viruses as vaccines.

Page last modified on 12 dec 11 16:17

Bookmark and Share